Publish in this journal
Journal Information
Vol. 66. Issue 2.
Pages 133 (February 2013)
Share
Share
Download PDF
More article options
Vol. 66. Issue 2.
Pages 133 (February 2013)
Update: Innovation in Cardiology
DOI: 10.1016/j.rec.2012.09.012
Full text access
Innovation in Cardiology: Introduction
Innovación en cardiología: introducción
Visits
...
Pablo Avanzasa,??
Corresponding author
rec@revespcardiol.org

Corresponding author: Revista Española de Cardiología, Sociedad Española de Cardiología, Ntra. Sra. de Guadalupe 5, 28028 Madrid, Spain.
, Antoni Bayes-Genisa, Leopoldo Pérez de Islaa, Juan Sanchisa, Magda Herasb
a Asociate Editor, Revista Española de Cardiología
b Editor-in-Chief, Revista Española de Cardiología
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text

.

Given the importance of continuing medical education in our specialty, Revista Española de Cardiología presents a new Update section. In previous years, we have dealt with such interesting subjects as “Cardiovascular diseases in women” (2006),1 “Noncoronary arterial disease” (2007),2 “Cardiovascular prevention” (2008),3 “Cardiovascular translational medicine” (2009),4 “The right heart and pulmonary circulation” (2010),5 “Systemic diseases and the cardiovascular system” (2011),6 and “Arrhythmias” (2012).7

In this new volume of the Update section for 2013, we examine the subject of “Innovation in cardiology”. Cardiology is a specialty that has always been in the vanguard of technological innovation. Especially in recent years, the introduction of new technological tools has opened the door to a revolution in both diagnostic and therapeutic developments. Cardiac imaging techniques are evolving rapidly (3-dimensional echocardiography, computed tomography with measurement of coronary fractional flow reserve, etc.) and are a central pillar in the diagnosis of many cardiovascular diseases. The development of new materials—such as catheters, bioprostheses specifically designed for percutaneous implantation, and stents—has facilitated the application of effective therapeutic solutions with an excellent risk-benefit ratio. Moreover, as in the case of bioabsorbable stents, this development has served to boost the most advanced basic and clinical research.

As in previous volumes, throughout the various articles an attempt has been made to deal with the most contemporary topics, those that will continue to change cardiology. Consequently, in line with the journal's policy, we have solicited manuscripts from highly prestigious authors with extensive experience in the various topics addressed. The first article (by Dr. Ibáñez) analyzes the future of imaging techniques, with special attention paid to those that can be combined to allow the patient to undergo a single examination. Prof. Clemmensen will portray the present and future of telemedicine8 and the new electrocardiographic monitoring systems, applied to pacemakers, defibrillators, and patients with heart failure. Prof. Ackerman will apprise us on the state of personalized medicine9 and genetic diagnosis. Dr. Gálvez will analyze the present and future of cardiac tissue engineering and organogenesis.10 In the field of interventional cardiology, the next articles will deal with the present and future of distinct techniques employed to treat various diseases: renal denervation in the case of hypertension11 (Prof. Krum), the implantation of coronary stents in coronary artery disease12 (Prof. Serruys), and percutaneous mitral repair in cases of mitral regurgitation13 (Prof. Rodés). Prof. Mayr presents a highly attractive and interesting subject, the biological approach to diagnostics involving metabolomics and proteomics.14

We hope that the contents of this series will be of interest and will appeal to readers of Revista Española de Cardiología. It is our wish that the series will, to put it quite appropriately, “update” the reader on these interesting but often unfamiliar topics, and that these articles will provide a practical view of how we will be putting these new tools to use in the near future and of how they will change our relationship with the patient and heart disease.

References
[1]
F. Alfonso, J. Bermejo, J. Segovia.
Enfermedades cardiovasculares en la mujer: ¿por qué ahora?.
Rev Esp Cardiol, 59 (2006), pp. 259-263
[2]
F. Alfonso, J. Segovia, M. Heras, J. Bermejo.
Patología arterial no coronaria: ¿de interés para el cardiólogo?.
Rev Esp Cardiol, 60 (2007), pp. 179-183
[3]
F. Alfonso, J. Segovia, M. Heras, J. Bermejo.
Prevención cardiovascular: ¿siempre demasiado tarde?.
Rev Esp Cardiol, 61 (2008), pp. 291-298
[4]
J. Bermejo, M. Heras, J. Segovia, F. Alfonso.
Medicina cardiovascular traslacional. Ahora o nunca.
Rev Esp Cardiol, 62 (2009), pp. 66-68
[5]
J. Segovia, J. Bermejo, F. Alfonso, M. Heras.
Corazón derecho y circulación pulmonar: una circulación menor?.
Rev Esp Cardiol, 63 (2010), pp. 77-80
[6]
L. Pérez de Isla, P. Avanzas, A. Bayes-Genis, J. Sanchis, M. Heras.
Enfermedades sistémicas y corazón: introducción.
Rev Esp Cardiol, 64 (2011), pp. 60-61
[7]
A. Bayes-Genis, P. Avanzas, L. Pérez de Isla, J. Sanchis, M. Heras.
Arritmias: introducción.
Rev Esp Cardiol, 65 (2012), pp. 91
[8]
P. Clemmensen, S. Loumann-Nielsen, M. Sejersten.
Telemedicine fighting acute coronary syndromes.
J Electrocardiol, 43 (2010), pp. 615-618
[9]
M.J. Ackerman.
Personalized medicine.
J Med Pract Manage, 25 (2009), pp. 194-195
[10]
A. Bayes-Genis, C. Gálvez-Montón, C. Prat-Vidal, C. Soler-Botija.
Cardiac adipose tissue: A new frontier for cardiac regeneration?.
[11]
M.P. Schlaich, H. Krum, P.A. Sobotka, M.D. Esler.
Renal denervation and hypertension.
Am J Hypertens, 24 (2011), pp. 635-642
[12]
C.V. Bourantas, Y. Zhang, V. Farooq, H.M. Garcia-Garcia, Y. Onuma, P.W. Serruys.
Bioresorbable scaffolds: current evidence and ongoing clinical trials.
Curr Cardiol Rep, 14 (2012), pp. 626-634
[13]
O.F. Bertrand, F. Philippon, A. St Pierre, C.M. Nguyen, E. Larose, S. Bilodeau, et al.
Percutaneous mitral valve annuloplasty for functional mitral regurgitation: acute results of the first patient treated with the Viacor permanent device and future perspectives.
Cardiovasc Revasc Med, 11 (2010), pp. e1.265-e1.268
[14]
T. Thum, M. Mayr.
Review focus on the role of microRNA in cardiovascular biology and disease.
Cardiovasc Res, 93 (2012), pp. 543-544
Copyright © 2012. Sociedad Española de Cardiología
Idiomas
Revista Española de Cardiología (English Edition)

Subscribe to our newsletter

Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?